Recent Updates
Recently added Catalysts
EXOZ Positive Sentiment

Biomass Magazine: Why Use Living Cells? NLR Is Making Chemicals With Enzymes Alone

Key Takeaway: Researchers at the U.S. National Laboratory of the Rockies (NLR) are investigating cell-free biomanufacturing, which utilizes engineered enzyme cascades instead of living cells. This innovative approach has the potential to revolutionize the bioenergy sector, as well as pharmaceuticals and fine chemicals. NLR Principal Scientist Yannick Bomble highlights the growing investment in this technology.
Price reaction · baseline $8.42 (2026-06-29 close) · hit after-hours · clean, no other EXOZ news in the window
day 0 close · peak
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Cell-free biomanufacturing could transform multiple sectors.
  • The technology allows for precise engineering of enzyme cascades.
  • It is gaining significant interest from researchers and companies.

Full Press Release Details

“ Cell-free biocatalysis for biomanufacturing - or cell-free biomanufacturing - essentially operates enzymatic cascades without the constraints of a living cell. This is a technology that could transform the bioenergy sector but also pharma and fine chemicals, ” explained Yannick Bomble , a National Laboratory of the Rockies (NLR) principal scientist and an R&D leader in cell-free biomanufacturing.
Why use living cells at all?” That’s the question researchers at the U.S. National Laboratory of the Rockies (NLR) are asking as they explore cell-free biomanufacturing—a rapidly emerging approach that replaces living microbes with precisely engineered enzyme cascades. In a new feature, NLR Principal Scientist Yannick Bomble explains why the technology could reshape not only bioenergy, but also pharmaceuticals and fine chemicals. It’s an excellent overview of why so many researchers and companies are investing in the future of cell-free manufacturing.
Click here for the full article in Biomass Magazine

Frequently Asked Questions

What is cell-free biomanufacturing?

Cell-free biomanufacturing uses engineered enzyme cascades instead of living cells.

Who is leading the research on this technology?

Yannick Bomble, a principal scientist at NLR, is leading the research.

What sectors could benefit from this technology?

The technology could transform bioenergy, pharmaceuticals, and fine chemicals.

Why are researchers investing in cell-free manufacturing?

Researchers see potential in its ability to precisely engineer biomanufacturing processes.

Last updated: Jun 29, 2026